Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-25T09:03:49.235Z Has data issue: false hasContentIssue false
  • English
  • Français

Effectiveness of Risperidone in Psychogenic Stiff Neck

Published online by Cambridge University Press:  07 November 2014

Donatella Marazziti  and
Bernardo Dell'Osso
Get access Rights & Permissions [Opens in a new window]

Abstract

A 48-year-old woman suffering from treatment-resistant psychogenic stiff neck and severe depression had been treated with a varied regimen of medications, including antidepressants, neuroleptics, and antiepileptics. These treatments did not result in improvement. Therefore, she was treated with a combination of sertraline and risperidone. Depressive symptoms decreased within a few weeks of treatment initiation. The psychogenic stiff neck, which had begun to improve within the first 2 weeks, had disappeared completely after 6 months of treatment with risperidone alone. This case report suggests that risperidone may be effective in some neurological motor disorders comorbid with mood disorders.

Type
Case Report
Information
CNS Spectrums , Volume 10 , Issue 6 , June 2005 , pp. 443 - 444
Copyright
Copyright © Cambridge University Press 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Rummans, TA, Lauterbach, EC, Coffey, CE, et al. Pharmacologic efficacy in neuropsychiatry: a review of placebo-controlled treatment trials. A report of the ANPA Committee on Research. J Neuropsychiatry Clin Neurosci. 1999;11:176–189.Google Scholar
2. Anderson, KE. Psychogenic movement disorders. Curr Treat Options Neurol. 2003;5:169–172.Google Scholar
3. Flinn, D, Bazzel, W. Psychiatric aspects of abnormal movement disorders. Brain Res Bull. 1983;11:153–161.Google Scholar
4. Gilbert, DL, Batterson, JR, Sethuraman, G, Sallee, FR. Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial. J Am Acad Child Adolesc Psychiatry. 2004;43:206–214.CrossRefGoogle Scholar
5. Parsa, MA, Szigethy, E, Voci, JM, Meltzer, HY. Risperidone in treatment of choreoathetosis of Huntington's disease. J Clin Psychopharmacol. 1997;17:134–135.Google Scholar
6. Evidente, VG, Gwinn-Hardy, K, Caviness, JN, Alder, CH. Risperidone is effective in severe hemichorea/hemiballismus. Mov Disord. 1999;14:377–379.Google Scholar
7. Factor, SA, Molho, ES, Friedman, JH. Risperidone and Parkinson's disease. Mov Disord. 2002;17:221–222.Google Scholar